In cancer, MDSCs induced the upregulation of IL-10 that downregulates macrophage IL-6 and IL-12 and tumor necrosis factor (TNFα) production, thereby polarizing tumor-associated macrophages (TAMs) toward a tumor-promoting M2 phenotype (3–5). This evidence concerns the gene TNF and cancer.